Data updated: Mar 29, 2026
SITAGLIPTIN
SITAGLIPTIN PHOSPHATE
Details
- Status
- None (Tentative Approval)
- First Approved
- N/A
- Routes
- FILM COATED
- Dosage Forms
- TABLET
Companies
MANKIND PHARMA LTD MSN LABORATORIES PRIVATE LTD BIOCON PHARMA LTD LAURUS LABS LTD SCIEGEN PHARMACEUTICALS INC FOSUN WANBANG (JIANGSU) PHARMACEUTICAL GROUP CO.,
Active Ingredient: SITAGLIPTIN PHOSPHATE
Website: ↗
SITAGLIPTIN Approval History
Loading approval history...
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
|
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
SITAGLIPTIN FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.